Chen YC, Jeng WJ, Chien RN, Liaw YF, et al. Switching to entecavir >3 months before the end of tenofovir-based therapy in HBeAg-negative patients may reduce early relapse and hepatitis flare. Am J Gastroenterol 2025 Jul 2. doi: 10.14309/ajg.0000000000003630.
PMID: 40600959